Recent reports have indicated that MDM2 expression in HCC is correlated with increased malignancy, epithelial-mesenchymal transition (EMT) progression, higher degree of invasiveness, and greater metastatic potential [23–25]. This evidence concerns the gene MDM2 and hepatocellular carcinoma.